FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: ACHN

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc. witnessed volume of 6.51 million shares during last trade however it holds an average trading capacity of 2.30 million shares.

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc witnessed volume of 3.67 million shares during last trade however it holds an average trading capacity of 1.58 million shares.

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc witnessed volume of 3.99 million shares during last trade however it holds an average trading capacity of 1.37 million shares.

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc witnessed volume of 4.76 million shares during last trade however it holds an average trading capacity of 1.13 million shares.

Crown Equity Holdings Inc. (CRWE)

Video communication is an efficient means of reaching prospective customers, of promoting the presentation of your products or services. The use of videos on the Internet brings numerous advantages.

Read full article at: http://pennyomega.com/19298/stock-alerts/crwe-shlo-achn-infi-stock-under...

Tags:

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc witnessed volume of 6.82 million shares during last trade however it holds an average trading capacity of 906,330 shares.

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc witnessed volume of 6.04 million shares during last trade however it holds an average trading capacity of 717,301 shares.

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Achillion Pharmaceuticals, Inc achieved its new 52 week high price of $9.86 where it was opened at $9.34 UP 1.80 points or +22.73% by closing at $9.72.

Pages

ADVERTISE WITH US